Litcius/Paper detail

Endocrinopathy After Treatment for Medulloblastoma: Results From the SJMB03 Trial of Risk-Adapted Radiation Therapy

Thomas E. Merchant, Shengjie Wu, Arzu Onar‐Thomas, Angela Delaney, Amar Gajjar

2022International Journal of Radiation Oncology*Biology*Physics11 citationsDOI

Topics & Concepts

MedicineHazard ratioMedulloblastomaInternal medicineCumulative incidenceGrowth hormone deficiencyThyroidConfidence intervalEndocrinologyPrecocious pubertyRadiation therapyIncidence (geometry)HormoneGastroenterologyGrowth hormoneCohortPathologyOpticsPhysicsGlioma Diagnosis and TreatmentChildhood Cancer Survivors' Quality of LifePituitary Gland Disorders and Treatments
Endocrinopathy After Treatment for Medulloblastoma: Results From the SJMB03 Trial of Risk-Adapted Radiation Therapy | Litcius